News Conference News TCT 2025 DOAC May Be Safer Than DAPT After Left Atrial Appendage Closure: ANDES Yael L. Maxwell November 04, 2025
News Conference News CRT 2025 Need for Rethink of Discharge Medications After LAA Closure? EMERGE L.A. McKeown March 12, 2025
News Conference News AHA 2024 OPTION: LAAO Matches Up to DOACs After Ablation, but Questions Remain Todd Neale November 18, 2024
News Conference News TCT 2024 LAAO Outcomes Similar Regardless of Operator’s Specialty Todd Neale October 27, 2024
News Daily News Dropping Aspirin From Post-LAAO Regimens Seems Like a Good Idea Todd Neale August 27, 2024
News Daily News Registry Data Reassure on Safety With Next-Generation Watchman Device L.A. McKeown July 30, 2024
News Daily News Outcomes Suffer When Device-Related Thrombus Persists or Recurs After LAAO Todd Neale November 29, 2023
News Conference News TCT 2023 WATCH-TAVR: Adding LAAO to TAVI No Worse Than TAVI Alone Todd Neale October 24, 2023
News Daily News LAAO Tops Oral Anticoagulation for AF in Women and Men: Medicare Analysis Todd Neale February 24, 2023
News Conference News HFSA 2022 No Benefit of LAA Ligation During HeartMate 3 Implantation: MOMENTUM 3 Yael L. Maxwell October 07, 2022
News Daily News NCDR Analyses Offer Insights Into First-Generation Watchman Outcomes L.A. McKeown May 03, 2022
News Conference News AHA 2021 Lariat LAA Ligation Doesn’t Boost Effect of AF Ablation: aMAZE Trial Todd Neale November 18, 2021
News Daily News FDA Investigating Possible Sex Differences in LAAO Outcomes Todd Neale September 27, 2021
News Conference News ESC 2021 Amulet IDE: LAA Occluder Performs Well Against Watchman Todd Neale August 30, 2021
News Conference News TVT 2021 New-Generation Watchman FLX Maintains Good Results Through 2 Years Todd Neale July 28, 2021
News Conference News HRS 2020 PINNACLE FLX: New-Generation Watchman Has High Closure Rates, Good Safety Todd Neale May 15, 2020
News Daily News Structural Heart Interventions in the Midst of COVID-19: Today’s Advice, Tomorrow’s Unknowns Shelley Wood April 13, 2020
News Conference News ESC 2019 Reduced-Dose Rivaroxaban May Be an Option After LAA Occlusion, ADRIFT Hints Todd Neale September 11, 2019
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for April 2018 Caitlin E. Cox April 30, 2018